Anthony Markham
Impact in
- Pharmaceutical Science top 1%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Blood Pressure and Hypertension Studies 10
- Renin-Angiotensin System Studies 6
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- Susan J. Keam (7 shared papers)Diana M. Faulds (6 shared papers)Karen L. Goa (4 shared papers)Rachel H. Foster (2 shared papers)Karen J. McClellan (5 shared papers)Delyth Clemett (3 shared papers)Heather D. Langtry (4 shared papers)Caroline M. Perry (2 shared papers)
- Journals
- Drugs (132 papers)Drugs & Aging (6 papers)Biochemical Pharmacology (6 papers)Biochemical Society Transactions (5 papers)British Journal of Pharmacology (3 papers)
- Partner nations
- New ZealandUnited KingdomGermany
In The Last Decade
Anthony Markham
169 papers receiving 10.5k citations
Peers
Comparison fields: 5 of 141
- Pharmaceutical Science 326
- Oncology 952
- Transplantation 135
- Pharmacology 587
- Pharmacology 361
Countries citing papers authored by Anthony Markham
This map shows the geographic impact of Anthony Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Markham more than expected).
Fields of papers citing papers by Anthony Markham
This network shows the impact of papers produced by Anthony Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Markham. The network helps show where Anthony Markham may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Markham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 349 | |
| 2 | 2000 | 314 | |
| 3 | 1997 | 282 | |
| 4 | 1996 | 260 | |
| 5 | 2000 | 233 | |
| 6 | 2019 | 221 | |
| 7 | 2019 | 217 | |
| 8 | 2000 | 180 | |
| 9 | 1999 | 169 | |
| 10 | 1995 | 164 | |
| 11 | 1999 | 157 | |
| 12 | 1996 | 154 | |
| 13 | 1996 | 154 | |
| 14 | 2017 | 153 | |
| 15 | 2021 | 152 | |
| 16 | 2018 | 151 | |
| 17 | 1997 | 142 | |
| 18 | 1999 | 135 | |
| 19 | 1994 | 133 | |
| 20 | 2019 | 133 |
About Anthony Markham
Anthony Markham is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Hematology, Oncology and Infectious Diseases, having authored 171 papers that have together received 11.3k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (13 papers), Blood Pressure and Hypertension Studies (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Asthma and respiratory diseases (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers), Renin-Angiotensin System Studies (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). The work is most often cited by research in Pharmaceutical Science (326 citations), Oncology (952 citations), Transplantation (135 citations), Pharmacology (587 citations) and Pharmacology (361 citations). Anthony Markham has collaborated with scholars based in New Zealand, United Kingdom and Germany. Frequent co-authors include Susan J. Keam, Diana M. Faulds, Karen L. Goa, Rachel H. Foster, Karen J. McClellan, Delyth Clemett, Heather D. Langtry, Caroline M. Perry, Michelle I. Wilde and Sean T. Duggan. Their work appears in journals such as Drugs, Drugs & Aging, Biochemical Pharmacology, Biochemical Society Transactions and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.